How the Pandemic has Accelerated Collaboration: A CDMO Perspective


22nd Sep 2021



Date: 22 September 2021
Time: New York – 10:00 | London – 15:00 | Paris – 16:00 | Singapore – 22:00
Duration: 75 minutes
Event structure: 10-min introduction + 45-min panel discussion + 20-min Q&A
Registration fee: Complimentary access
Webinar on-demand: Available to view until midnight 8th October 2021 (registration is required)


2020, the year of the SARS-CoV-2 pandemic, has accelerated unique global collaboration between academia, government, biotech, pharma, and the manufacturing industry, leading to scientific breakthroughs and advanced medicines being produced at unprecedented speed. How has this been possible and what can we learn from our experiences? In this webinar, contract development and manufacturing organisation Cobra Biologics, now a Charles River company, is joined by special guests to discuss.

Discussion points:

  • CHALLENGES – the hurdles from a CDMO, drug developer, and supplier perspective
  • IMPACT – the changing approaches to collaboration and, in turn, drug production
  • LEARNINGS – applying knowledge and collaborative frameworks in a post-pandemic world


Register For Free


Sponsored by:



Tony Hitchcock
Technical Director – Cobra Biologics, a Charles River Company


Philip Ridley-Smith
Sales and Marketing Director – Cobra Biologics, a Charles River Company

Prof. Matti Sällberg
Head of Department of Laboratory Medicine – Karolinska Institute

Byron Rees
Senior SLS Manager – Pall Life Sciences

Dr. Alexander (Sandy) Douglas
Research Group Leader – Jenner Institute, University of Oxford



Cobra Biologics: A Charles River Company

Cobra Biologics, now a Charles River company, is a leading international contract development and manufacturing organization (CDMO) specializing in premium plasmid DNA and viral vector services to support the Advanced Therapy Medicinal Products (ATMP) industry.

Each of our GMP approved facilities are tailored to serving clients from early stage, to clinical, to commercial scale. Our team takes pride in manufacturing excellence and supporting drug development for the benefit of patients worldwide.

Our mission is to continue to expand and cultivate our CDMO offerings in the cell and gene therapy space, providing supply chain simplification through an end-to-end service for development, testing, and manufacturing. We provide our clients with an integrated solution from basic research and discovery through to GMP production.


The meeting is free to attend


Register Today

Interested in hosting your own webinar or online panel discussion?

With over a decade of experience in hosting life science events, Global Engage is your ideal partner to either devise an agenda for you or work with you and your speakers to promote the online event to our extensive databases.

Contact us to discuss how we can make a webinar / online panel discussion work for you

For further details please contact
Gavin Hambrook
Telephone +44 (0) 7538 368 764 or
email [email protected]

Reuben Raj
Telephone: +603 2117 5193 or
email [email protected]